Erno Duda

Our service helps companies achieve their sustainability goals by transforming office food waste into local, green, environmentally regenerative action in a trackable way. Employees can playfully engage with ESG goals at an individual and community level, making impact a part of the corporate culture. Eco-ethically produced in Hungary. 🇭🇺

Neunos Ltd is combining the latest advances of neuroscience with cutting-edge microelectronic approaches in order to provide a therapeutic solution based on oscillatory interference with ongoing neuronal network activity. We develop a minimally-invasive, implantable seizure suppression system, which automatically detects the onset of epileptic seizures and promptly terminates them by transcranial electrical stimulation before fatal accidents evolve. Treating epileptic seizures is our main focus, however we are continuously looking for new opportunities and alternative perspectives to deepen our knowledge in neuropsychiatric disorders, and find new non-pharmaceutical therapeutic approaches. Join us in making an impact by changing lives today.

SigmaDrugs is a Budapest based biotech start-up company founded in 2015. We are dedicated to developing novel applications of Sigma-1 receptor agonists for the treatment of chronic fibrotic diseases including end-stage renal failure, idiopathic pulmonary fibrosis as well as fibrosis in the eye. Preclinical studies have been completed, the patent has been accepted in the US, Europe, Israel, China, and Japan. In parallel, SigmaDrugs Ltd is also developing a patented preservation solution for organ transplantation which promotes protection of the graft, thus alleviating donor organ shortage and facilitating improved transplantation outcomes.

Life Science accelerator

Our service helps companies achieve their sustainability goals by transforming office food waste into local, green, environmentally regenerative action in a trackable way. Employees can playfully engage with ESG goals at an individual and community level, making impact a part of the corporate culture. Eco-ethically produced in Hungary. 🇭🇺

Neunos Ltd is combining the latest advances of neuroscience with cutting-edge microelectronic approaches in order to provide a therapeutic solution based on oscillatory interference with ongoing neuronal network activity. We develop a minimally-invasive, implantable seizure suppression system, which automatically detects the onset of epileptic seizures and promptly terminates them by transcranial electrical stimulation before fatal accidents evolve. Treating epileptic seizures is our main focus, however we are continuously looking for new opportunities and alternative perspectives to deepen our knowledge in neuropsychiatric disorders, and find new non-pharmaceutical therapeutic approaches. Join us in making an impact by changing lives today.

We are a premium healthcare company focused on introducing you to your body like never before. Our comprehensive health service combines medical examinations, imaging, microbiome analysis, metabolomics, genomics, and medical history processing for a holistic evaluation of your health. Our mission is simple - to help you maximize your health using cutting-edge technology and evidence-based science for disease risk prediction, early detection, and actionable insights. With Medipredict, you can take proactive steps towards preventive and predictive healthcare, empowering informed decisions about your well-being. Join us on this journey towards a healthier you. Trust Medipredict for personalized health solutions backed by scientific expertise and delivered with care. Let us be your trusted partner in achieving and maintaining optimal health.

SigmaDrugs is a Budapest based biotech start-up company founded in 2015. We are dedicated to developing novel applications of Sigma-1 receptor agonists for the treatment of chronic fibrotic diseases including end-stage renal failure, idiopathic pulmonary fibrosis as well as fibrosis in the eye. Preclinical studies have been completed, the patent has been accepted in the US, Europe, Israel, China, and Japan. In parallel, SigmaDrugs Ltd is also developing a patented preservation solution for organ transplantation which promotes protection of the graft, thus alleviating donor organ shortage and facilitating improved transplantation outcomes.

Life Science accelerator